Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Rosales Castillo (Ciudad de México, Mexico), V. Peláez-Hernández (Ciudad de México, Mexico), L. Martínez-Bautista (Ciudad de México, Mexico), A. Orea-Tejeda (Ciudad de México, Mexico), K. Santillán-Reyes (Ciudad de México, Mexico), G. Luna-Rodríguez (Ciudad de México, Mexico), M. Gómez Martínez (Ciudad de México, Mexico), M. Quintero Martínez (Ciudad de México, Mexico). QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS. 3264

Member's Comments

No comment yet.

Related content which might interest you: PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 IMPACT OF TELEMONITORING ON PATIENTS WITH ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 DIFFERENCES IN PSYCHOLOGICAL FACTORS BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 RELATIONSHIP BETWEEN SIX-MINUTE WALK DISTANCE, PULMONARY FUNCTIONS AND PATIENT CENTERED OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects Year: 2018 BURDEN STUDY OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION FOR COLOMBIA POPULATION Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 IMPACT OF CHRONIC ANEMIA ON THE EVOLUTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION (COPDE) Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 CORRELATION BETWEEN LUNG AND JOINT INVOLVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE: CROSS SECTIONAL STUDY Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 TEMPORAL RESOLUTION OF RIGHT VENTRICLE DYSFUNCTION IN PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY. Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 IMPACT OF NON-INVASIVE VENTILATION IMMEDIATELY AFTER EXTUBATION ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS SUBMITTED TO CORONARY ARTERY BYPASS GRAFTING: CLINICAL TRIAL Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training Year: 2021 FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON PULMONARY FUNCTION IN MIDDLE-AGE AND OLDER PATIENTS WITH TYPE 2 DIABETES Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017